EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress

NEXT STORY
Global $8.2Bn Oligonucleotide Synthesis Market by 2024 – Opportunities in Emerging Asian Markets
PREV STORY
HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease

PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 (darvadstrocel) has ...

author_avatar
NASDAQ Market News

Global Infection Surveillance Solutions Market Will Reach USD 956 Million By 2026: Zion Market Research

author_avatar
NASDAQ Market News

Angion Announces Several Strategic Additions to its Management Team to Support the Future Development and Commercialization of ANG-3777

author_avatar
NASDAQ Market News